Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,298,294
+$1,219,366 QoQ
Shares Held
88,640
+35.2% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 252 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALLIANCEBERNSTEIN L.P. holds $5,177,847,011 across 257 Biotechnology names. CLDX ranks #81 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,019,315 | $1,499,784,339 | |
| 2 | ARGX |
Argenx SE
|
395,661 | $367,082,405 | |
| 3 | GMAB |
Genmab A/S
|
8,644,877 | $237,474,771 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
292,338 | $182,284,436 | |
| 5 | TECH |
BIO-TECHNE Corp
|
2,002,026 | $141,443,136 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,696,538 | $132,788,029 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
981,521 | $112,551,013 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,453,504 | $108,256,977 |
All Filings in CLDX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,298,294 | 88,640 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,078,928 | 65,540 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,780,066 | 65,540 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,695,519 | 65,540 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,333,739 | 65,540 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,189,551 | 65,540 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,656,195 | 65,540 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,227,704 | 65,540 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,425,635 | 65,540 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,589,968 | 61,710 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,144,812 | 54,080 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,567,093 | 93,281 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,770,467 | 52,180 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,507,562 | 41,900 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,867,483 | 41,900 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $1,177,809 | 41,900 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $1,129,624 | 41,900 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,396,460 | 41,000 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,580,376 | 40,900 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,208,191 | 40,900 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $1,367,696 | 40,900 | Shares | Defined | 2021-07-30 | |
| No filing history on record for this holder in this stock. | ||||||